Market Tracker

12/01 5:17pm ET

AstraZeneca PLC (NASDAQ:AZN)

68.34
Delayed Data
As of Dec 01
 +0.39 / +0.57%
Today’s Change
52.65
Today|||52-Week Range
71.70
+17.32%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$205.2B

Company Description

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. It focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. These pharmaceutical products are then manufactured, marketed and sold. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Contact Information

AstraZeneca Plc
Cambridge Biomedical Campus
Cambridge Cambridgeshire CB2 0AA
P:442037495000
Investor Relations:

Employees

Shareholders

Mutual fund holders9.98%
Other institutional7.29%
Individual stakeholders--

Top Executives

Pascal SoriotChief Executive Officer & Executive Director
Pam P. ChengExecutive VP-Operations & Information Technology
Aradhana SarinChief Financial Officer & Executive Director
Menelas NICOLAS PangalosEVP-Biopharmaceuticals Research & Development
Henry D. CremisiMedical Director